Zabdeno Market Report 2026

Zabdeno Market Overview

• The Zabdeno market growth in the historic period has been driven by recurrent ebola outbreaks in high-risk regions, global emergency vaccination initiatives • Market expansion is supported by increasing investments in outbreak preparedness, rising focus on next-generation viral vaccines • Growth Driver: Rising Incidence Of Ebola Virus Disease To Drive Growth In The Market • North America was the largest region in 2025.

What Is Covered Under Zabdeno Market?

Zabdeno is a combination vaccine designed to provide protection against Ebola virus disease. It contains two components one that targets the Zaire ebolavirus and another that targets the Sudan ebolavirus. Administered as a two-dose regimen, Zabdeno is used for pre-exposure prophylaxis in individuals at high risk of Ebola virus exposure, offering a crucial tool in preventing outbreaks. The main types of zabdeno are single-dose vaccines, two-dose vaccines. Single-dose vaccines offer quick and efficient protection against ebola virus disease with just one shot helping control outbreaks, especially in high-risk areas. This vaccine is used for indication that include ebola virus disease and are distributed through various distribution channels such as hospitals and clinics, retail pharmacies, online pharmacies, wholesale distribution and are also used by various end-users such as adult, geriatric.

What Is The Zabdeno Market Growth Forecast?

The growth in the forecast period can be attributed to increasing investments in outbreak preparedness, rising focus on next-generation viral vaccines, expansion of global immunization coverage, growing use of genomic surveillance for virus variants, increasing international health security collaborations. Major trends in the forecast period include expansion of ebola pre-exposure vaccination programs, increasing focus on two-dose vaccine compliance, growing stockpiling for outbreak preparedness, rising emphasis on cold-chain optimized vaccines, strengthening public-private vaccine partnerships.

Global Zabdeno Market Segmentation

1) By Vaccine Type: Single-Dose Vaccines, Two-Dose Vaccines 2) By Indication: Ebola Virus Disease 3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Wholesale Distribution 4) By End-User: Adult, Geriatric

What Are The Drivers Of The Zabdeno Market?

The increasing incidences of ebola viral disease are expected to propel the growth of the zabdeno market going forward. Ebola viral disease (EVD), also known simply as Ebola, is a severe and often fatal illness caused by the Ebola virus, which belongs to the Filoviridae family. The increasing incidences of ebola viral disease are due to a combination of factors, including increased human-wildlife interactions and insufficient surveillance and containment measures in high-risk regions, which facilitate the transmission and spread of the virus. Zabdeno, a vaccine developed to combat ebola viral disease, helps protect patients by stimulating the immune system to recognize and fight off the virus, thereby reducing the risk of infection and potentially preventing the severe, life-threatening symptoms associated with the disease. For instance, in January 2023, according to the World Health Organization, a Switzerland-based health organization, approximately 164 ebola cases (142 confirmed, 22 probable) with 77 deaths (55 among confirmed cases and 22 among probable cases) and 87 recovered patients. Therefore, the increasing incidences of ebola viral disease drive the zabdeno industry. Increasing immunization programs is expected to propel the growth of the zabdeno market going forward. Immunization programs are structured public health initiatives designed to protect individuals and populations from infectious diseases by administering vaccines. The increasing immunization programs are due to the growing recognition of their effectiveness in preventing the spread of infectious diseases, and the expansion of global vaccination coverage. Immunization programs enhance the effectiveness and reach of zabdeno by providing widespread protection against infectious diseases, thereby reducing disease burden, increasing herd immunity, and fostering healthier populations, which in turn allows zabdeno to be more impactful in promoting overall public health outcomes. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the International Coordinating Group (ICG) Ebola vaccine stockpile, which reached 500,000 doses in 2022, had grown to 518,890 doses by December 2023, reflecting an increase of 3.8% in just one year. Therefore, increasing immunization programs drives the zabdeno industry. The rising healthcare expenditure is expected to propel the growth of the zabdeno market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure is expected to support the growth of the Zabdeno by enabling increased investment in advanced vaccines and facilitating broader access to preventive therapies for infectious diseases. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the zabdeno industry.

Key Players In The Global Zabdeno Market

Major companies operating in the zabdeno market are Johnson & Johnson Inc.

Regional Insights

North America was the largest region in the zabdeno market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zabdeno Market?

The zabdeno market consists of sales of zabdeno (Ad26.ZEBOV) and mvabea (MVA-BN-Filo). Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Zabdeno Market Report 2026?

The zabdeno market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the zabdeno industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.